Patent details

EP2430183 Title: ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE

Basic Information

Publication number:
EP2430183
PCT Application Number:
PCT/US/2010/035045
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP107192247
PCT Publication Number:
WO/2010/132866
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE
French Title of Invention:
TRAITEMENT ANTIPSYCHOTIQUE BASÉ SUR UN GÉNOTYPE DE SNP DRD2 OU ANKK1
German Title of Invention:
ANTIPSYCHOTISCHE BEHANDLUNG AUF DER BASIS DES DRD2- ODER ANKK1-SNP-GENOTYPS
SPC Number:

Dates

Filing date:
15/05/2010
Grant date:
17/12/2014
EP Publication Date:
17/12/2014
PCT Publication Date:
18/11/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/03/2012
EP B1 Publication Date:
17/12/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/05/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/05/2010
 
 

Name:
Vanda Pharmaceuticals Inc.
Address:
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037, United States (US)

Agent

Name:
ARONOVA S.A.
From:
17/03/2015
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
VOLPI Simona
Address:
United States (US)

2

Name:
LAVEDAN Christian
Address:
United States (US)

Priority

Priority Number:
178934 P
Priority Date:
15/05/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/68;

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
27/05/2024
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages